Intravitreal corticosteroids and macular edema, a meta-analysis

Publication Date

2015

Document Type

Research

Abstract

This meta-analysis showed evidence that intravitreal corticosteroids can be used as primary treatment for macular edema of various etiologies. There is a need for more large randomized trials using various available steroids either intravitreally or topically versus macular edema to investigate its true benefit and risks for it to become a viable therapeutic option. More studies comparing its benefits and risks with those of laser and anti-vascular endothelial growth factor therapy must also be made. Intravitreal corticosteroids are a new option in posterior ocular segment disease and further long term clinical research must focus on these to determine optimal treatment parameters.

Comments

Call Number: RP OPT 15 01

Location: Research Commons

This document is currently not available here.

Share

COinS